Literature DB >> 12893105

HIV disease progression: depression, stress, and possible mechanisms.

Jane Leserman1.   

Abstract

There is much interest in whether depression and stress may explain the wide variability in the disease course of patients infected with human immunodeficiency virus (HIV). This article summarizes the large body of evidence examining whether depression and stress may have an impact on immune- and disease-related parameters in HIV disease. Furthermore, we review what is known about the underlying biological mechanisms of HIV disease, such as alterations in glucocorticoids and catecholamines, which may help explain these psychoimmune relationships. Our review of the literature finds substantial evidence that chronic depression and stressful events may affect HIV disease progression. We know little, however, regarding the biological mechanisms that may account for these relationships. More research is warranted to investigate how depression and stress might impact HIV disease progression and what types of interventions might mitigate the negative impact of chronic depression and trauma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893105     DOI: 10.1016/s0006-3223(03)00323-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  108 in total

1.  Benefits of adherence to psychotropic medications on depressive symptoms and antiretroviral medication adherence among men and women living with HIV/AIDS.

Authors:  Dean G Cruess; Seth C Kalichman; Christine Amaral; Connie Swetzes; Chauncey Cherry; Moira O Kalichman
Journal:  Ann Behav Med       Date:  2012-04

2.  A systematic review: the role of spirituality in reducing depression in people living with HIV/AIDS.

Authors:  Roxanna Amuzie; Melvyn Jones
Journal:  Br J Gen Pract       Date:  2012-02       Impact factor: 5.386

3.  Effects of HIV and early life stress on amygdala morphometry and neurocognitive function.

Authors:  Uraina S Clark; Ronald A Cohen; Lawrence H Sweet; Assawin Gongvatana; Kathryn N Devlin; George N Hana; Michelle L Westbrook; Richard C Mulligan; Beth A Jerskey; Tara L White; Bradford Navia; Karen T Tashima
Journal:  J Int Neuropsychol Soc       Date:  2012-05-24       Impact factor: 2.892

Review 4.  Neuropsychiatric complications of aging with HIV.

Authors:  Crystal C Watkins; Glenn J Treisman
Journal:  J Neurovirol       Date:  2012-05-30       Impact factor: 2.643

Review 5.  Drug treatment of depression in HIV-positive patients : safety considerations.

Authors:  Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 6.  Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.

Authors:  Crystal C Watkins; Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

7.  Optimizing the effects of stress management interventions in HIV.

Authors:  Conall O'Cleirigh; Steven Safren
Journal:  Health Psychol       Date:  2008-05       Impact factor: 4.267

8.  Impact of intimate partner violence on clinic attendance, viral suppression and CD4 cell count of women living with HIV in an urban clinic setting.

Authors:  Jocelyn C Anderson; Jacquelyn C Campbell; Nancy E Glass; Michele R Decker; Nancy Perrin; Jason Farley
Journal:  AIDS Care       Date:  2018-04

Review 9.  Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.

Authors:  Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2016-09-22       Impact factor: 3.455

10.  HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework.

Authors:  Valerie A Earnshaw; Laramie R Smith; Stephenie R Chaudoir; K Rivet Amico; Michael M Copenhaver
Journal:  AIDS Behav       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.